Acarbose (Prandase) is now approved for use in COMBINATION with a sulfonylurea
June 1997
Acarbose (Prandase) is now approved for use in combination with a sulfonylurea. It was originally approved as monotherapy.
This combination makes sense.
Each drug works in a different way to lower blood sugar. Together they have additive effects.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive